Clinical Trials Logo

Breakthrough Cancer Pain clinical trials

View clinical trials related to Breakthrough Cancer Pain.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT04713189 Not yet recruiting - Clinical trials for Breakthrough Cancer Pain

Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With Breakthrough Cancer Pain

Start date: March 15, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

Breakthrough cancer pain (BTcP) is a common problem in patients with cancer. This is a phase I/IIa, pharmacokinetic, dose-response and safety study of inhaled fentanyl aerosol (25µg/dose) in Chinese patients with breakthrough cancer pain. The study will include two stages.